cytosine has been researched along with Papillomavirus Infections in 100 studies
Papillomavirus Infections: Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.
Excerpt | Relevance | Reference |
---|---|---|
"No recurrence was observed in nine patients over an average follow-up period of 24." | 2.69 | Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study. ( Calista, D, 2000) |
" This study reviews the published dosing regimens of intralesional cidofovir in the treatment of RRP in order to provide a precedent for those that wish to prescribe it." | 2.49 | Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis. ( Clamp, PJ; Saunders, MW, 2013) |
"Imiquimod was released recently for therapy of genital warts." | 2.40 | Therapy of human papillomavirus infection and associated epithelial tumors. ( Gross, G, 1997) |
"To evaluate the recurrence pattern, the larynx was divided into 10 subsites, and patients were investigated for the frequency of recurrence at the subsites after the operation." | 1.43 | Is recurrent respiratory papillomatosis a manageable or curable disease? ( Baizhumanova, AS; Kim, HT, 2016) |
"Human papillomavirus (HPV) causes cervical cancer and a large fraction of head and neck squamous cell carcinomas (HNSCC)." | 1.43 | Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms. ( Andrei, G; Mertens, B; Naesens, L; Nogueira, T; Snoeck, R; Stranska, R, 2016) |
"Problem of treatment is the high recurrence of papilloma growth after surgical removal; therefore adjuvant therapy schemes have been established." | 1.39 | Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis. ( Friedrich, G; Graupp, M; Gugatschka, M; Hammer, G; Kiesler, K; Reckenzaun, E, 2013) |
" Administration should remain below established safe limits of dosing (3 mg/kg) and volume." | 1.39 | Current use of intralesional cidofovir for recurrent respiratory papillomatosis. ( Chadha, NK; Derkay, CS; Froehlich, P; McMurray, JS; Pransky, SM; Rosen, CA; Volsky, PG, 2013) |
"Condyloma, also known as venereal warts, are caused by human papillomavirus (HPV)." | 1.35 | [Treatment of pediatric genital condyloma]. ( Dommergues, C; Quinet, B, 2008) |
"Nearly all cervical cancers are associated with the high-risk subtypes of human papillomavirus (HPV) expressing the E6 and E7 oncoproteins." | 1.33 | Enhanced antiproliferative effects of alkoxyalkyl esters of cidofovir in human cervical cancer cells in vitro. ( Aldern, KA; Beadle, JR; Corbeil, J; Hostetler, KY; Rought, S; Trahan, J, 2006) |
"Human papillomavirus infection is one of the most common and most distressing cutaneous diseases in patients with HIV infection." | 1.33 | Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection. ( Kottke, MD; Parker, SR, 2006) |
" Complete cures were obtained using 1% (w/v) topical cidofovir at dosing schedules of twice daily for 8 weeks beginning at 4 weeks after CRPV infection, which represents a time when papillomas were clearly visible." | 1.31 | In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas. ( Budgeon, LR; Christensen, ND; Kreider, JW; Pickel, MD, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (8.00) | 18.2507 |
2000's | 42 (42.00) | 29.6817 |
2010's | 47 (47.00) | 24.3611 |
2020's | 3 (3.00) | 2.80 |
Authors | Studies |
---|---|
Napolitano, L | 1 |
Schroedl, L | 1 |
Kerman, A | 1 |
Shea, CR | 1 |
Solarz, P | 1 |
Bodnar, M | 1 |
Czech, J | 1 |
Mackiewicz-Nartowicz, H | 1 |
Sinkiewicz, A | 1 |
Szylberg, Ł | 1 |
Borowczak, J | 1 |
Rutkiewicz, P | 1 |
Zwierz, A | 1 |
Burduk, P | 1 |
Richardson, BE | 1 |
Jones, SEF | 1 |
Hibbitts, S | 1 |
Hurt, CN | 1 |
Bryant, D | 1 |
Fiander, AN | 1 |
Powell, N | 1 |
Tristram, AJ | 1 |
Carifi, M | 1 |
Ciarrocca, K | 1 |
Jackson, LL | 1 |
De Rossi, SS | 1 |
Manickavasagam, J | 1 |
Wu, K | 1 |
Bateman, ND | 1 |
Dikkers, FG | 4 |
Clamp, PJ | 2 |
Saunders, MW | 2 |
Durvasula, VS | 1 |
Richter, GT | 1 |
Chirilă, M | 2 |
Bolboacă, SD | 1 |
Moore, JE | 1 |
Garcia, A | 1 |
Sanyal, S | 1 |
Saunders, S | 1 |
Portnoy, JE | 1 |
Hu, A | 1 |
Sataloff, RT | 2 |
Grasso, M | 2 |
Remacle, M | 4 |
Bachy, V | 1 |
Van Der Vorst, S | 1 |
Lawson, G | 3 |
Christensen, ND | 2 |
Cladel, NM | 1 |
Hu, J | 1 |
Balogh, KK | 1 |
San Giorgi, MR | 1 |
Tjon Pian Gi, RE | 3 |
Andrei, G | 6 |
Topalis, D | 3 |
De Schutter, T | 3 |
Snoeck, R | 12 |
Murono, S | 2 |
Nakanishi, Y | 2 |
Tsuji, A | 2 |
Endo, K | 2 |
Kondo, S | 2 |
Wakisaka, N | 2 |
Yoshida, H | 1 |
Yoshizaki, T | 2 |
Liekens, S | 1 |
Noppen, S | 1 |
Gijsbers, S | 1 |
Sienaert, R | 1 |
Ronca, R | 1 |
Tobia, C | 1 |
Presta, M | 1 |
Fusconi, M | 1 |
Greco, A | 1 |
Gallo, A | 1 |
Campo, F | 1 |
Turchetta, R | 1 |
Pagliuca, G | 1 |
DE Vincentiis, M | 1 |
Milutin Gašperov, N | 1 |
Sabol, I | 1 |
Planinić, P | 1 |
Grubišić, G | 1 |
Fistonić, I | 1 |
Ćorušić, A | 1 |
Grce, M | 1 |
Karatayli-Ozgursoy, S | 1 |
Bishop, JA | 1 |
Hillel, A | 1 |
Akst, L | 1 |
Best, SR | 1 |
Kim, HT | 1 |
Baizhumanova, AS | 1 |
Zeitels, SM | 1 |
Sendagorta, E | 1 |
Bernardino, JI | 1 |
Álvarez-Gallego, M | 1 |
Feíto, M | 1 |
Feltes, R | 1 |
Beato, MJ | 1 |
Pérez-Molina, JA | 1 |
Yllescas, M | 1 |
Díaz-Almirón, M | 1 |
Arribas, JR | 1 |
González-García, J | 1 |
Herranz, P | 1 |
Nogueira, TC | 1 |
El Amri, C | 1 |
Krečmerová, M | 1 |
Naesens, L | 4 |
Balzarini, J | 2 |
Mertens, B | 1 |
Nogueira, T | 1 |
Stranska, R | 1 |
Pi Sala, N | 1 |
Figueras Suriol, A | 1 |
Ramió Montero, E | 1 |
Drejet, S | 1 |
Halum, S | 1 |
Brigger, M | 1 |
Skopelja, E | 1 |
Parker, NP | 1 |
Catalani, S | 1 |
Palma, F | 1 |
Battistelli, S | 1 |
Nuvoli, B | 1 |
Galati, R | 1 |
Benedetti, S | 1 |
Meacham, RK | 1 |
Thompson, JW | 1 |
Carvalho, CM | 1 |
Huot, L | 1 |
Charlois, AL | 1 |
Khalfallah, SA | 1 |
Chapuis, F | 1 |
Froehlich, P | 6 |
Van Pachterbeke, C | 1 |
Bucella, D | 1 |
Rozenberg, S | 1 |
Manigart, Y | 1 |
Gilles, C | 1 |
Larsimont, D | 1 |
Vanden Houte, K | 1 |
Reynders, M | 1 |
Bossens, M | 3 |
Culton, DA | 1 |
Morrell, DS | 1 |
Burkhart, CN | 1 |
Muñoz, RM | 1 |
Prado, E | 1 |
Cisneros, JM | 1 |
Bautista, FJ | 1 |
Donne, AJ | 3 |
Hampson, L | 2 |
He, XT | 2 |
Day, PJ | 1 |
Salway, F | 1 |
Rothera, MP | 3 |
Homer, JJ | 3 |
Hampson, IN | 2 |
Rivière, F | 1 |
Gille, T | 1 |
Le Tinier, JY | 1 |
Gharbi, N | 1 |
Khalil, A | 1 |
Wislez, M | 1 |
Cadranel, J | 1 |
Collette, DC | 1 |
Zechel, MA | 1 |
Ksiazek, J | 1 |
Prager, JD | 1 |
Sun, GH | 1 |
Wood, RE | 1 |
Arjmand, EM | 1 |
Wierzbicka, M | 2 |
Jackowska, J | 2 |
Bartochowska, A | 1 |
Józefiak, A | 1 |
Szyfter, W | 1 |
Kędzia, W | 1 |
Darwich, E | 1 |
Darwich, L | 1 |
Cañadas, MP | 1 |
Klaustermeier, J | 1 |
Ercilla, G | 1 |
Alsina-Gibert, M | 1 |
Mascaró, JM | 1 |
Gáll, T | 1 |
Kis, A | 1 |
Fehér, E | 1 |
Gergely, L | 1 |
Szarka, K | 1 |
Dietz, A | 2 |
Djukic, V | 1 |
Eckel, HE | 1 |
Friedrich, G | 3 |
Golusinski, W | 2 |
Hantzakos, A | 2 |
Rihkanen, H | 1 |
Di Lucca-Christment, J | 1 |
Jacobelli, S | 1 |
Gressier, L | 1 |
Plantier, F | 1 |
Laude, H | 1 |
Rozenberg, F | 1 |
Rosenberg, F | 1 |
Morini, JP | 1 |
Dallot, A | 1 |
Avril, MF | 1 |
Dupin, N | 1 |
Gormley, RH | 1 |
Kovarik, CL | 1 |
DeFatta, RA | 1 |
Sataloff, JB | 1 |
Klaris, GE | 1 |
Mikolajczak, S | 1 |
Quante, G | 1 |
Weissenborn, S | 1 |
Wafaisade, A | 1 |
Wieland, U | 1 |
Lüers, JC | 1 |
Klussmann, JP | 1 |
Beutner, D | 1 |
Fox, PA | 1 |
Graupp, M | 2 |
Gugatschka, M | 1 |
Kiesler, K | 1 |
Reckenzaun, E | 1 |
Hammer, G | 1 |
Derkay, CS | 1 |
Volsky, PG | 1 |
Rosen, CA | 1 |
Pransky, SM | 1 |
McMurray, JS | 1 |
Chadha, NK | 1 |
Duraffour, S | 1 |
Mitera, T | 1 |
van den Oord, J | 1 |
Matthys, P | 1 |
Nathan, M | 1 |
Ilmarinen, T | 1 |
van den Heuvel, ER | 1 |
Aaltonen, LM | 1 |
Andersen, J | 1 |
Brunings, JW | 1 |
Ferran Vilà, F | 1 |
de Gier, HH | 1 |
Horcasitas, R | 1 |
Koelmel, JC | 1 |
Lindner, F | 1 |
Sittel, C | 1 |
Weichbold, V | 1 |
Coulombeau, B | 2 |
Nusa Naiman, A | 1 |
Ceruse, P | 1 |
Johnson, JA | 2 |
Gangemi, JD | 2 |
Milczuk, HA | 1 |
Ramos, E | 1 |
Drachenberg, CB | 1 |
Portocarrero, M | 1 |
Wali, R | 1 |
Klassen, DK | 1 |
Fink, JC | 1 |
Farney, A | 1 |
Hirsch, H | 1 |
Papadimitriou, JC | 1 |
Cangro, CB | 1 |
Weir, MR | 1 |
Bartlett, ST | 1 |
Bernard, HU | 1 |
DeRossi, SS | 1 |
Laudenbach, J | 1 |
Kendall, KA | 1 |
Naiman, AN | 3 |
Roger, G | 1 |
Gagnieu, MC | 1 |
Bordenave, J | 1 |
Mathaut, S | 1 |
Ayari, S | 3 |
Nicollas, R | 2 |
Bour, JB | 2 |
Garabedian, N | 1 |
Toutous-Trellu, L | 1 |
Hirschel, B | 1 |
Piguet, V | 1 |
Schiffer, V | 1 |
Saurat, JH | 1 |
Pechère, M | 1 |
Sirianni, N | 1 |
Wang, J | 1 |
Ferris, RL | 1 |
Derkay, C | 1 |
De Clercq, E | 6 |
Leyssen, P | 1 |
Neyts, J | 1 |
Pannecouque, C | 1 |
Ying, C | 1 |
Hocková, D | 1 |
Holý, A | 1 |
Lee, JH | 1 |
Smith, RJ | 1 |
Tasca, RA | 1 |
McCormick, M | 1 |
Clarke, RW | 1 |
Hostetler, KY | 1 |
Rought, S | 1 |
Aldern, KA | 1 |
Trahan, J | 1 |
Beadle, JR | 1 |
Corbeil, J | 1 |
Tan, HH | 1 |
Goh, CL | 1 |
Abedipour, D | 1 |
Fresnel, E | 1 |
Kottke, MD | 1 |
Parker, SR | 1 |
Landry, G | 1 |
Colombeau, B | 1 |
Shrestha, S | 1 |
Wang, C | 1 |
Aissani, B | 1 |
Wilson, CM | 1 |
Tang, J | 1 |
Kaslow, RA | 1 |
Briand, S | 1 |
Milpied, B | 1 |
Navas, D | 1 |
Thomare, P | 1 |
Stalder, JF | 1 |
Dommergues, C | 1 |
Quinet, B | 1 |
Peng, X | 1 |
Lang, CM | 1 |
Kreider, JW | 2 |
Van Cutsem, E | 1 |
Van Ranst, M | 2 |
Fiten, P | 1 |
Opdenakker, G | 1 |
Geboes, K | 1 |
Janssens, J | 1 |
Rutgeerts, P | 1 |
Vantrappen, G | 1 |
Gross, G | 1 |
Hou, J | 1 |
Major, EO | 1 |
Zabawski, EJ | 1 |
Cockerell, CJ | 1 |
Taoufik, Y | 1 |
Gasnault, J | 1 |
Karaterki, A | 1 |
Pierre Ferey, M | 1 |
Marchadier, E | 1 |
Goujard, C | 1 |
Lannuzel, A | 1 |
Delfraissy, JF | 1 |
Dussaix, E | 1 |
Orlando, G | 1 |
Fasolo, MM | 1 |
Beretta, R | 1 |
Signori, R | 1 |
Adriani, B | 1 |
Zanchetta, N | 1 |
Cargnel, A | 1 |
Noel, JC | 2 |
Muller, C | 1 |
Davis, MD | 1 |
Gostout, BS | 1 |
McGovern, RM | 1 |
Persing, DH | 1 |
Schut, RL | 1 |
Pittelkow, MR | 1 |
Held, TK | 1 |
Biel, SS | 1 |
Nitsche, A | 1 |
Kurth, A | 1 |
Chen, S | 1 |
Gelderblom, HR | 1 |
Siegert, W | 1 |
Dancey, DR | 1 |
Chamberlain, DW | 1 |
Krajden, M | 1 |
Palefsky, J | 1 |
Alberti, PW | 1 |
Downey, GP | 1 |
Calista, D | 2 |
Pickel, MD | 1 |
Budgeon, LR | 1 |
Parent, D | 1 |
Delaere, B | 1 |
Degreef, H | 1 |
Wulfsohn, MS | 1 |
Rooney, JF | 1 |
Jaffe, HS | 1 |
Van Laethem, Y | 1 |
De Maubeuge, J | 1 |
Clumeck, N | 1 |
Mahé, E | 1 |
Descamps, V | 1 |
Abdulkarim, B | 1 |
Sabri, S | 1 |
Deutsch, E | 1 |
Chagraoui, H | 1 |
Maggiorella, L | 1 |
Thierry, J | 1 |
Eschwege, F | 1 |
Vainchenker, W | 1 |
Chouaïb, S | 1 |
Bourhis, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients[NCT01946009] | 20 participants (Actual) | Interventional | 2013-09-30 | Completed | |||
TOPical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasm: a Randomized Controlled Trial.[NCT02329171] | Phase 3 | 9 participants (Actual) | Interventional | 2014-12-31 | Terminated (stopped due to Insufficient number of participants.) | ||
Efficacy and Safety of Topical Trichloroacetic Acid vs. Electrocautery for the Treatment of Anal Intraepithelial Neoplasia in HIV-positive Patients (TECAIN) - a Randomized Controlled Trial[NCT02615860] | 560 participants (Actual) | Interventional | 2015-11-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
18 reviews available for cytosine and Papillomavirus Infections
Article | Year |
---|---|
Intralesional cidofovir as adjuvant for the successful management of aggressive respiratory papillomatosis in an infant.
Topics: Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Administration Schedul | 2013 |
Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Cell Proliferation; Cidofovir; C | 2015 |
Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
Topics: Antiviral Agents; Cidofovir; Cytosine; Humans; Organophosphonates; Papillomavirus Infections; Respir | 2014 |
A Systematic Review.
Topics: Adult; Angiogenesis Inhibitors; Antiviral Agents; Bevacizumab; Cidofovir; Cytosine; Humans; Injectio | 2017 |
The management of condyloma acuminata in the pediatric population.
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antiviral Agents; Child; Child, Presch | 2009 |
Novel treatment of atypical human papillomavirus-associated epithelial hyperplasia with cidofovir.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Anus Neoplasms; Cidofovir; Cytosine; Epithe | 2011 |
Human papillomavirus-related genital disease in the immunocompromised host: Part II.
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents, Phytogenic; Ant | 2012 |
Treatment options for anal intraepithelial neoplasia and evidence for their effectiveness.
Topics: Adult; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anus Neoplasms; Cido | 2012 |
Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Cidofovir; Cytosine; Humans; Injections, Intralesional; Organophosphonates; Papill | 2013 |
Established and potential strategies against papillomavirus infections.
Topics: Aminoquinolines; Antimetabolites; Antiviral Agents; Cidofovir; Cytosine; Drug Design; Fluorouracil; | 2004 |
Recurrent respiratory papillomatosis: pathogenesis to treatment.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Cidofovir; Cytosine; Human papillomavirus 11; Human p | 2005 |
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Ad | 2006 |
Papillomavirus and treatment.
Topics: Antiviral Agents; Carcinoma; Chemotherapy, Adjuvant; Cidofovir; Cytosine; Female; Humans; Organophos | 2006 |
Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Cidofovir; Cytosine; Humans; Neoplasm Recurrence, Local; Organophosphonates; Papil | 2008 |
Therapy of human papillomavirus infection and associated epithelial tumors.
Topics: Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine | 1997 |
Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
Topics: Administration, Cutaneous; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; | 1998 |
Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature.
Topics: Adult; Antiviral Agents; Biopsy; Cidofovir; Cystic Adenomatoid Malformation of Lung, Congenital; Cyt | 2000 |
Cidofovir in the treatment of HPV-associated lesions.
Topics: Administration, Topical; Antiviral Agents; Apoptosis; Cell Division; Cidofovir; Cytosine; Female; Hu | 2001 |
8 trials available for cytosine and Papillomavirus Infections
Article | Year |
---|---|
Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: a pilot clinical trial.
Topics: Administration, Topical; Adult; Antiviral Agents; Anus Neoplasms; Biopsy; Carcinoma in Situ; Cidofov | 2016 |
Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study.
Topics: Administration, Topical; Adult; Antineoplastic Agents; Cidofovir; Combined Modality Therapy; Conizat | 2009 |
[Treatment of cutaneous human papilloma virus, poxvirus and herpes simplex virus infections with topical cidofovir in HIV positive patients].
Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Female; Herpes Simplex; HIV I | 2004 |
Intermediate-term and long-term results after treatment by cidofovir and excision in juvenile laryngeal papillomatosis.
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modality Therapy; | 2006 |
Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).
Topics: Adult; Antiviral Agents; Biopsy; Cervix Uteri; Cidofovir; Conization; Cytosine; Female; Humans; Immu | 2000 |
Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; C | 2000 |
Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Male; Middle Aged; Organophosphonates; | 2001 |
[A new antiviral for genito-anal condylomas].
Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; Double | 2002 |
74 other studies available for cytosine and Papillomavirus Infections
Article | Year |
---|---|
Topical cidofovir for benign human papillomavirus-associated skin lesions.
Topics: Alphapapillomavirus; Cidofovir; Cytosine; Humans; Organophosphonates; Papillomaviridae; Papillomavir | 2021 |
Assessment of immunomodulation and regulation of cell cycle in epithelium and stroma after Cidofovir injection in patients with recurrent respiratory papillomatosis-Pilot study.
Topics: Antiviral Agents; Cell Cycle; Cidofovir; Cytosine; Epithelium; Humans; Immunomodulation; Laryngeal N | 2023 |
Initial Experience Treating HPV-Related Laryngeal Diseases with Oral Brincidofovir: A Pilot Study.
Topics: Administration, Oral; Adult; Alphapapillomavirus; Antiviral Agents; Cytosine; Dose-Response Relation | 2021 |
Human Papillomavirus DNA Methylation Predicts Response to Treatment Using Cidofovir and Imiquimod in Vulval Intraepithelial Neoplasia 3.
Topics: Aminoquinolines; Biomarkers; Carcinoma in Situ; Cidofovir; Cytosine; DNA Methylation; DNA, Viral; Dr | 2017 |
Use of cidofovir in recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Cytosine; Female; Humans; Male; Organophosphonates; Papillomavirus Infections; Res | 2013 |
Human papillomavirus: the fundamentals of HPV for oral health care providers.
Topics: Antiviral Agents; Cidofovir; Cytosine; HIV Infections; Humans; Mouth Neoplasms; Organophosphonates; | 2013 |
Treatment of paediatric laryngeal papillomas: web survey of British Association of Paediatric Otolaryngologists.
Topics: Anticarcinogenic Agents; Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Health Ca | 2013 |
Letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
Topics: Antiviral Agents; Cytosine; Humans; Organophosphonates; Papillomavirus Infections; Respiratory Tract | 2013 |
Response to Dikkers letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
Topics: Antiviral Agents; Cytosine; Humans; Organophosphonates; Papillomavirus Infections; Respiratory Tract | 2013 |
Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis.
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; Female; Follow-Up | 2014 |
Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Male; Middle Aged; Organophosphonates; Papill | 2013 |
Use of cidofovir in HPV patients with recurrent respiratory papillomatosis.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Injections, I | 2014 |
Formulation of cidofovir improves the anti-papillomaviral activity of topical treatments in the CRPV/rabbit model.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Chemistry, Pharmaceutical; Cidofovir | 2014 |
The clinical course of recurrent respiratory papillomatosis after the use of cidofovir is influenced by multiple factors.
Topics: Cytosine; Female; Humans; Male; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Res | 2015 |
Trends in the management of recurrent respiratory papillomatosis in Japan.
Topics: Antiviral Agents; Cidofovir; Cytosine; Debridement; Disease Management; Humans; Japan; Laser Therapy | 2015 |
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.
Topics: Animals; Antiviral Agents; Apoptosis; Blotting, Western; Cell Proliferation; Cidofovir; Cytosine; Em | 2015 |
Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer.
Topics: Adult; Biomarkers; Cell Line; Cervix Uteri; CpG Islands; Cytosine; DNA Methylation; DNA, Viral; Fema | 2015 |
Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma; Cell Transfor | 2016 |
Is recurrent respiratory papillomatosis a manageable or curable disease?
Topics: Adolescent; Adult; Aged; Antiviral Agents; Chemotherapy, Adjuvant; Child; Cidofovir; Combined Modali | 2016 |
Glottic Cancer: A Metamorphosing Disease.
Topics: Adolescent; Adult; Antiviral Agents; Carcinoma, Squamous Cell; Cidofovir; Cytosine; Diagnostic Error | 2016 |
Resistance to the nucleotide analogue cidofovir in HPV(+) cells: a multifactorial process involving UMP/CMP kinase 1.
Topics: ATP-Binding Cassette Transporters; Cell Line, Tumor; Cidofovir; Cytidine Triphosphate; Cytosine; Dru | 2016 |
Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
Topics: Adult; Aged; Antiviral Agents; Cidofovir; Cytosine; Female; Human papillomavirus 6; Humans; Injectio | 2016 |
Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms.
Topics: Antiviral Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cidofovir; Cytosine; DNA Damage; Femal | 2016 |
[Intralesional cidofovir in human papilomavirus infection in interdigital spaces].
Topics: Antiviral Agents; Cidofovir; Cytosine; Fingers; Humans; Infusions, Intralesional; Male; Middle Aged; | 2017 |
Reduced cell viability and apoptosis induction in human thyroid carcinoma and mesothelioma cells exposed to cidofovir.
Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cidofovir; Cyto | 2017 |
Comparison of cidofovir and the measles, mumps, and rubella vaccine in the treatment of recurrent respiratory papillomatosis.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modality Therapy; Cytosin | 2017 |
Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients.
Topics: Adult; Antineoplastic Agents; Child; Child, Preschool; Cidofovir; Cytosine; Databases, Factual; Fema | 2009 |
[Cidofovir gel 1% for treating papillomavirus lesions in a patient with congenital immunodeficiency].
Topics: Anemia, Hemolytic, Congenital; Antiviral Agents; Cidofovir; Cytosine; Female; Fingers; Gels; Hand De | 2010 |
Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
Topics: Antiviral Agents; Cell Line; Cell Survival; Cidofovir; Cytosine; Gene Expression Profiling; Gene Exp | 2009 |
Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion.
Topics: Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Infusions, Intravenous; Lung; Middle Aged; Or | 2011 |
Inhaled cidofovir as an adjuvant therapy for recurrent respiratory papillomatosis.
Topics: Administration, Inhalation; Aerosols; Antineoplastic Agents; Antiviral Agents; Cidofovir; Cytosine; | 2011 |
Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Cidofovir; Cohort Studies; Cyto | 2011 |
New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; | 2011 |
Virological failure of intralesional cidofovir therapy in recurrent respiratory papillomatosis is not associated with genetic or epigenetic changes of HPV11: complete genome comparison of sequential isolates.
Topics: Antiviral Agents; Cidofovir; Cytosine; DNA Methylation; DNA, Viral; Epigenesis, Genetic; Genome, Vir | 2011 |
Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
Topics: Adverse Drug Reaction Reporting Systems; Antiviral Agents; Cidofovir; Cytosine; Injections, Intrales | 2012 |
Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Carcinoma, Squamous Cell; Cidofovir; | 2012 |
Laryngeal papilloma.
Topics: Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Humans; Injections, Intralesional; | 2012 |
The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; DNA, Viral; Female; Human papillomavirus 11; Human pap | 2012 |
Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cy | 2013 |
Current use of intralesional cidofovir for recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Chemotherapy, Adjuvant; Cidofovir; Cross-Sectional Studies; Cytosine; Humans; Inje | 2013 |
Cidofovir treatment improves the pathology caused by the growth of human papillomavirus-positive cervical carcinoma xenografts in athymic nude mice.
Topics: Animals; Antineoplastic Agents; Brain; Cachexia; Carcinoma; Cell Line, Tumor; Cidofovir; Cytokines; | 2013 |
Treatment of anal intraepithelial neoplasia: has it come of age?
Topics: Antiviral Agents; Anus Neoplasms; Carcinoma in Situ; Cidofovir; Cytosine; Female; HIV Infections; Hu | 2013 |
Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
Topics: Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Female; Head and Neck Neoplasms; H | 2013 |
Anti-cancer agents. Will cidofovir be useful against cervical lesions?
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Organophosphonates; Organophosphorus C | 2000 |
[Anti-viral injectable treatment (cidofovir) in laryngeal papillomatosis].
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modality Therapy; | 2002 |
Alpha interferon augments cidofovir's antiviral and antiproliferative activities.
Topics: Antiviral Agents; Blotting, Western; Cell Line, Transformed; Cidofovir; Colony Count, Microbial; Cyc | 2003 |
Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children.
Topics: Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; Female; Humans; Infant; Injections, | 2003 |
BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Humans; Immunosuppressive Agents; Incidence; Kidney | 2002 |
The management of oral human papillomavirus with topical cidofovir: a case report.
Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Diagnosis, Differential; Gels | 2004 |
Current treatment for laryngeal papillomatosis.
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modalit | 2004 |
Cidofovir plasma assays after local injection in respiratory papillomatosis.
Topics: Adult; Aged; Antiviral Agents; Area Under Curve; Child; Child, Preschool; Chromatography, High Press | 2004 |
Antiviral activity of Cidofovir on a naturally human papillomavirus-16 infected squamous cell carcinoma of the head and neck (SCCHN) cell line improves radiation sensitivity.
Topics: Adult; Antiviral Agents; Blotting, Western; Carcinoma, Squamous Cell; Cell Survival; Cidofovir; Cyto | 2005 |
Cidofovir for recurrent respiratory papillomatosis (RRP): a re-assessment of risks.
Topics: Animals; Antiviral Agents; Carcinogens; Child; Cidofovir; Cytosine; Drug Approval; Humans; Neoplasm | 2005 |
Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
Topics: Adenoviridae; Adenoviridae Infections; Animals; Anti-HIV Agents; Antiviral Agents; Cell Line; Cidofo | 2005 |
British Association of Paediatric Otorhinolaryngology members experience with recurrent respiratory papillomatosis.
Topics: Anticarcinogenic Agents; Antiviral Agents; Child; Cidofovir; Cytosine; Databases, Factual; Health Ca | 2006 |
Enhanced antiproliferative effects of alkoxyalkyl esters of cidofovir in human cervical cancer cells in vitro.
Topics: Antineoplastic Agents; Cell Proliferation; Cidofovir; Cytosine; Drug Screening Assays, Antitumor; Es | 2006 |
Natural history of adult-onset laryngeal papillomatosis following multiple cidofovir injections.
Topics: Adult; Antiviral Agents; Biopsy; Cidofovir; Cytosine; DNA, Viral; Female; Follow-Up Studies; Human p | 2006 |
Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection.
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Humans; Injections, Intravenous; Male; Organophosphona | 2006 |
Effects of cidofovir on a novel cell-based test system for recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Blotting, Western; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Flow Cyt | 2007 |
Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents.
Topics: Adolescent; Adult; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Child; Cohort Studies; Cytosine | 2007 |
1% topical cidofovir used as last alternative to treat viral infections.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; | 2008 |
[Treatment of pediatric genital condyloma].
Topics: Adult; Aminoquinolines; Antiviral Agents; Child; Cidofovir; Condylomata Acuminata; Cytosine; Humans; | 2008 |
Methylation of cottontail rabbit papillomavirus DNA and tissue-specific expression in transgenic rabbits.
Topics: 5-Methylcytosine; Animals; Animals, Genetically Modified; Cottontail rabbit papillomavirus; Cytosine | 1995 |
Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.
Topics: Aged; Antiviral Agents; Cidofovir; Cytosine; Esophageal Neoplasms; Female; Humans; Hypopharyngeal Ne | 1995 |
The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line.
Topics: Anti-HIV Agents; Antiviral Agents; Brain; Cells, Cultured; Cidofovir; Cytarabine; Cytosine; DNA, Vir | 1998 |
Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.
Topics: AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count | 1998 |
Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
Topics: Antiviral Agents; Cell Cycle; Cell Transformation, Viral; Cells, Cultured; Cidofovir; Cytosine; Huma | 1999 |
Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
Topics: Administration, Topical; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Condylo | 1999 |
Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Biopsy; Cid | 2000 |
Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytomegalovirus; Cytomegalovirus Infections; Cytosi | 2000 |
Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir.
Topics: Anti-Infective Agents, Local; Antiviral Agents; Cidofovir; Cytosine; Gingival Diseases; HIV Infectio | 2000 |
In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas.
Topics: Animals; Antiviral Agents; Cidofovir; Cottontail rabbit papillomavirus; Cytosine; Disease Models, An | 2000 |
Treatment of a bowenoid papulosis of the penis with local applications of cidofovir in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Antiviral Agents; Bowen's Diseas | 2001 |
Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.
Topics: Animals; Antiviral Agents; Carcinoma; Cell Division; Cidofovir; Cyclin A; Cyclin-Dependent Kinase In | 2002 |